Renal revascularization for uremia - Long-term outcome

被引:0
作者
Rossi, G [1 ]
Grossi, R [1 ]
Flum, DR [1 ]
机构
[1] ST VINCENTS HOSP, DEPT SURG, DIV VASC SURG, NEW YORK, NY USA
来源
VASCULAR SURGERY | 1996年 / 30卷 / 03期
关键词
D O I
10.1177/153857449603000311
中图分类号
R61 [外科手术学];
学科分类号
摘要
Renal revascularization for uremia has achieved variable success and remains a controversial procedure. The authors retrospectively reviewed their experience with renal revascularization to assess operative morbidity and mortality and to quantify its longterm, beneficial effects on renal function. From 1974 to 1993, 15 patients with renal artery occlusive disease and varying degrees of uremia underwent renal artery revascularization. A retrospective review was conducted of these patients. There were 9 men and 6 women with an average age of 61.5 years (range forty-five to eighty-three years). Preoperative serum creatinine ranged from 1.9 to 10 mg/dL with a mean of 5.07 mg/dL. Three groups were identified: Group A-creatinine 1.9-3.4 mg/dL, Group B-creatinine 3.5-5.2 mg/dL, Group C-patients receiving dialysis. Ten of 15 patients had a solitary kidney. Ten of 15 patients had concomitant aortic reconstruction with renal artery bypass. The mean creatinine went from 5.07 mg/dL preoperatively to 2.22 mg/dL on discharge (P = 0.006). At late follow up (mean 69.1 months) the mean creatinine was 2.62 mg/dL. Late (mean 69.1 months) functional results indicated that 13 of 15 patients (87%) had improved or stabilized renal function. Five of 7 patients who were receiving dialysis preoperatively required no postoperative dialysis because of improvements in renal function. One patient eventually required dialysis although he had not required it preoperatively. There were no operative deaths, but 2 major complications occurred. Mean survival time was one hundred seven months with 80% survival at five years and 60% survival at ten years. On average 63.6 months of dialysis-free survival were noted for the group. Renal revascularization for uremia can be performed with low morbidity and mortality. Long-term follow up indicates a low mortality and a lasting beneficial effect on renal function in the majority of patients. Additionally, this beneficial effect is recognized in patients already receiving preoperative dialysis.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 10 条
  • [1] ELMORE JR, 1988, ARCH SURG-CHICAGO, V123, P610
  • [2] OPERATIVE MORBIDITY AND MORTALITY IN RENOVASCULAR DISEASE
    FRANKLIN, SS
    YOUNG, JD
    MAXWELL, MH
    FOSTER, JH
    PALMER, JM
    CERNY, J
    VARADY, PD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 231 (11): : 1148 - 1153
  • [3] GIFFORD RW, 1973, GERIATRICS, V28, P124
  • [4] RENOVASCULAR OPERATIONS IN PATIENTS WITH CHRONIC RENAL-INSUFFICIENCY - DO THE BENEFITS JUSTIFY THE RISKS
    HALLETT, JW
    FOWL, R
    OBRIEN, PC
    BERNATZ, PE
    PAIROLERO, PC
    CHERRY, KJ
    HOLLIER, LH
    [J]. JOURNAL OF VASCULAR SURGERY, 1987, 5 (04) : 622 - 627
  • [5] NATURAL HISTORY OF RENAL ARTERIAL DISEASE
    MEANEY, TF
    DUSTAN, HP
    MCCORMAC.LJ
    [J]. RADIOLOGY, 1968, 91 (05) : 881 - &
  • [6] Mercier C, 1990, Ann Vasc Surg, V4, P166, DOI 10.1007/BF02001373
  • [7] SURGICAL TREATMENT OF RENAL FAILURE OF RENOVASCULAR ORIGIN
    MORRIS, GC
    COOLEY, DA
    DEBAKEY, ME
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 182 (06): : 609 - &
  • [8] NOVICK AC, 1984, UROL CLIN N AM, V11, P435
  • [9] SCHREIBER MJ, 1984, UROL CLIN N AM, V11, P383
  • [10] CLINICAL COURSE OF ATHEROSCLEROTIC RENOVASCULAR DISEASE
    WOLLENWEBER, J
    SHEPS, SG
    DAVIS, GD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1968, 21 (01) : 60 - +